MedPath

SPECTRO ECZEMACARE MEDICATED CREAM

SPECTRO ECZEMACARE MEDICATED CREAM

Approved
DIN Number

02214415

Drug Class

Human

Market Date

Sep 27, 1999

Company
HC

haleon canada ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02214415
AIG Number0113261001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D07AB01 CLOBETASONE
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:06.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLOBETASONE BUTYRATEActive
Strength: 0.05 % / W/W
Monograph: CLOBETASONE BUTYRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.